Prostaglandin E2 Resistance of Nasal Fibroblast in Aspirin Exacerbated Respiratory Disease Is Caused by Epigenetic Factor Defects in EP2 Receptor Expression

被引：0
|
作者：
Cahill, Katherine N. [1 ,2 ]
Kidder, Molly [1 ]
Bhattacharyya, Neil [2 ,3 ]
Borish, Larry [4 ]
Steinke, John W. [4 ]
Boyce, Joshua A. [1 ,2 ]
Laidlaw, Tanya M. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Div Otolaryngol, Boston, MA 02115 USA
[4] Univ Virginia, Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.1549
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB328 / AB328
页数：1
相关论文
共 50 条
  • [31] Prostaglandin E2 Inhibits the Proliferation of Human Gingival Fibroblasts Via the EP2 Receptor and Epac
    Weinberg, Evgeny
    Zeldich, Ella
    Weinreb, Max M.
    Moses, Ofer
    Nemcovsky, Carlos
    Weinreb, Miron
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (01) : 207 - 215
  • [32] Expression of the prostaglandin E2 receptors EP1, EP2, EP3 and EP4 in human kidney
    Morath, R
    Klein, T
    Seyberth, HW
    Nüsing, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R725 - R725
  • [33] Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression
    Konger, RL
    Scott, GA
    Landt, Y
    Ladenson, JH
    Pentland, AP
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06): : 2065 - 2078
  • [34] Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease
    Liang, XB
    Wang, Q
    Hand, T
    Wu, LJ
    Breyer, RM
    Montine, TJ
    Andreasson, K
    JOURNAL OF NEUROSCIENCE, 2005, 25 (44): : 10180 - 10187
  • [35] Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to an inhibition of platelet aggregation
    Kashiwagi, Hitoshi
    Kuriyama, Shuhko
    Yuhki, Koh-ichi
    Ushikubi, Fumitaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 62P - 62P
  • [36] Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation
    Kuriyama, Shuhko
    Kashiwagi, Hitoshi
    Yuhki, Koh-ichi
    Kojima, Fumiaki
    Yamada, Takehiro
    Fujino, Takayuki
    Hara, Akiyoshi
    Takayama, Koji
    Maruyama, Takayuki
    Yoshida, Akitoshi
    Narumiya, Shuh
    Ushikubi, Fumitaka
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (04) : 796 - 803
  • [37] Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E2 Activation in Human Podocytes
    Mangelsen, Eva
    Rothe, Michael
    Schulz, Angela
    Kourpa, Aikaterini
    Panakova, Daniela
    Kreutz, Reinhold
    Bolbrinker, Juliane
    CELLS, 2020, 9 (05)
  • [38] Prostaglandin E2 acts through EP2/EP4 receptors to upregulate RGS2 expression in osteoblasts
    Nunn, C.
    Dixon, S. J.
    Chidiac, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S247 - S247
  • [39] Afferent arteriolar responses to prostaglandin E2 (PGE2) and sulprostone in prostaglandin EP2 receptor deficient mice.
    Imig, JD
    Breyer, MD
    Breyer, RM
    FASEB JOURNAL, 2000, 14 (04): : A28 - A28
  • [40] CLONING AND EXPRESSION OF A CDNA FOR MOUSE PROSTAGLANDIN-E RECEPTOR EP2 SUBTYPE
    HONDA, A
    SUGIMOTO, Y
    NAMBA, T
    WATABE, A
    IRIE, A
    NEGISHI, M
    NARUMIYA, S
    ICHIKAWA, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (11) : 7759 - 7762
12345